SAMANTHA FREMBGEN: Open Payments
NPI 1275620239 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 45 payments from 8 companies in 2025. Trend: 2023 $1,075 · 2024 $863 · 2025 $1,065
Food & beverage: $1,065
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $370 |
| ABBVIE INC. | 16 | $286 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Alkermes, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $18 |
| Bausch Health US, LLC | 1 | $15 |
Products named: SPRAVATO, VRAYLAR, CAPLYTA, TRINTELLIX, ARISTADA, Auvelity, REXULTI, APLENZIN.
Industry payments across AZ — which companies pay providers there.
